Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HD-MTX and Liposomal Cytarabine for Breast Cancer CNS Metastases
NCT00992602Phase 2Completed
- Sponsor
- University of Washington
- Start
- Apr 2011
- Primary completion
- Jun 2013
- Modality
- Targeted Liposomes, Orthosteric Ligands, Stealth (PEGylated) Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of methotrexate, liposomal cytarabine in breast cancer, leptomeningeal metastases (LM), central nervous system metastases, sponsored by University of Washington. Started Apr 2011; status: completed.
02
Drugs
methotrexateliposomal cytarabine
03
Conditions
breast cancerleptomeningeal metastases (LM)central nervous system metastases
Beyond the preview
Go deeper on NCT00992602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00992602.